Novartis issues warning for breast cancer drug Femara
Novartis last week issued a warning that its breast cancer drug, Femara (letrozole), has been associated with birth defects, a ...
Your Email Address: *
Recipient(s) Email Address: *
(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)
The e-mail address(es) that you supply to use this service will only be used to send the requested article.